Tag: #Global Trends

German biotechnology developer T-CURX has entered into a definitive agreement to acquire its domestic peer, Pantherna Therapeutics, to systematically advance... Read more

Global contract development and manufacturing organization (CDMO) Intravacc and biotechnology developer Primrose Bio have formalized a definitive renewal of their... Read more

TOKYO (Reuters) — Japan's Shionogi & Co has announced that the U.S. Food and Drug Administration (FDA) has officially approved... Read more

The Coalition for Epidemic Preparedness Innovations (CEPI) has formalized a financial commitment of approximately $60 million distributed across Moderna and... Read more

The United States Food and Drug Administration (FDA) has granted formal regulatory approval to Shionogi’s antiviral medication, Xocova (ensitrelvir), specifically... Read more

Swiss pharmaceutical flagship Novartis announced Sunday that early-stage clinical data monitoring its experimental actinium-based radioligand candidate demonstrated pronounced anti-tumor activity... Read more

Healthcare conglomerate Johnson & Johnson (J&J) announced definitive clinical data from a pivotal late-stage Phase III trial showcasing that its... Read more

ZURICH (Reuters) — Swiss generic drug manufacturer Sandoz has formalized a draft anti-dumping complaint submitted to the European Commission over... Read more

U.S. pharmaceutical flagship Pfizer and Chinese drugmaker Innovent Biologics have entered into a definitive global licensing and collaboration agreement valued... Read more